Publication | Closed Access
A randomized trial in ovarian cancer (OC) of early treatment of relapse based on CA125 level alone versus delayed treatment based on conventional clinical indicators (MRC OV05/EORTC 55955 trials)
101
Citations
0
References
2009
Year
Surgical OncologyCancer ManagementGynecologyPathologyConventional Clinical IndicatorsGynecology OncologyMay 30Ovarian CancerNeuro-oncologyOncologyMetronomic TherapyCancer Cell BiologyClinical OncologyRandomized TrialRadiation OncologyCancer ResearchMolecular OncologyFinal TextCancer TreatmentMalignant DiseaseTumoral PathologyMedicine
1 The full, final text of this abstract will be available in Part II of the 2009 ASCO Annual Meeting Proceedings, distributed onsite at the Meeting on May 30, 2009, and as a supplement to the June 20, 2009, issue of the Journal of Clinical Oncology. No significant financial relationships to disclose.